<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To determine the functional outcome in a cohort of young adults with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> patients, focusing on components of <z:chebi fb="23" ids="18059">lipid</z:chebi> profile </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: In our registry including consecutive patients with first-ever <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> aged 15-49 from 1994 to 2007, we analyzed predictors of 3-month functional outcome (modified Rankin Scale, mRS) </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> size fell into small, medium, large posterior, or large anterior </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> severity was assessed with NIH <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale (NIHSS) </plain></SENT>
<SENT sid="4" pm="."><plain>Serum <z:chebi fb="23" ids="18059">lipids</z:chebi> were measured within 72 h after admission </plain></SENT>
<SENT sid="5" pm="."><plain>Binary, multinomial ordinal, and Poisson regressions allowed revealing factors associated with size of <z:mpath ids='MPATH_124'>infarct</z:mpath>, <z:hpo ids='HP_0001297'>stroke</z:hpo> severity, and unfavorable outcome or <z:hpo ids='HP_0011420'>death</z:hpo> (mRS, 2-6) or mRS as an ordinal measure </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In the 968 patients included (mean age, 41.3 Â± 7.6; 62.6% men; 49.5% with mRS 0-1), factors associated with unfavorable outcome after multivariable analysis were increasing age (odds ratio, 1.03 per year; 95% confidence interval, 1.01-1.05), higher NIHSS score (1.23 per point, 1.17-1.29), large anterior (4.37, 2.26-8.42) or posterior (1.73, 1.05-2.85) <z:mpath ids='MPATH_124'>infarcts</z:mpath>, bilateral lesions (2.28, 1.30-3.98), <z:e sem="disease" ids="C0751815" disease_type="Disease or Syndrome" abbrv="">internal carotid artery dissection</z:e> (ICAD) (3.65, 1.41-9.47), and inversely <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) levels (0.58 per unit increase, 0.38-0.86) </plain></SENT>
<SENT sid="7" pm="."><plain>Increasing <z:chebi fb="17" ids="39025">HDL</z:chebi> associated with smaller <z:mpath ids='MPATH_124'>infarct</z:mpath> size (0.71, 0.51-0.98) </plain></SENT>
<SENT sid="8" pm="."><plain>Both higher total and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> associated with lower NIHSS score (0.96, 0.93-0.98 for total cholesterol and 0.82, 0.75-0.88 for <z:chebi fb="17" ids="39025">HDL</z:chebi>) and lower 3-month mRS (0.87, 0.78-0.97 for total cholesterol and 0.65, 0.47-0.90 for <z:chebi fb="17" ids="39025">HDL</z:chebi>) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: In addition to known prognosticators, ICAD and lower <z:chebi fb="17" ids="39025">HDL</z:chebi> levels were independently associated with adverse clinical outcomes in our young adult <z:hpo ids='HP_0001297'>stroke</z:hpo> cohort </plain></SENT>
</text></document>